Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

SABSW

SAB Biotherapeutics, Inc.

CIK 0001833214 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$0.02
↑ 0.00 (31.62%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Ownership, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$1.18M
P/E Ratio
-2.96
EPS
0.22
Dividend Yield
Not covered
52W Position
5%
Beta
2.10

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.01
P/S
Not covered
EV/Revenue
Not covered
ROE
-0.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 5%
$0.01$0.18

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
$13.27M
Total Assets
$172.81M
Free Cash Flow
-$45.71M

Recent news